logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9913810 B1

PDFFull Text
Date of Patent:
Mar. 13, 2018

Filed:

Mar. 12, 2015

Composition and method to alleviate joint pain using phospholipids and astaxanthin

Applicant:

U.s. Nutraceuticals, Llc, Eustis, FL (US);

Inventors:

John A. Minatelli, Mount Dora, FL (US);

W. Stephen Hill, Ocala, FL (US);

Rudi E. Moerck, Sanford, FL (US);

Assignee:

U.S. NUTRACEUTICALS, LLC, Eustis, FL (US);

Attorney:

Allen, Dyer, Doppelt + Gilchrist, P.A.

Primary Examiner:

Erin M Bowers

Int. Cl.
CPC ...
A01N 31/04 (2006.01); A61K 31/122 (2006.01); A61K 31/728 (2006.01); A61K 31/661 (2006.01); A61K 31/6615 (2006.01); A61K 36/9066 (2006.01); A61K 45/06 (2006.01); A61K 31/202 (2006.01); A61K 31/685 (2006.01); A61K 31/7028 (2006.01); A61K 36/05 (2006.01); A61K 36/185 (2006.01); A61K 36/324 (2006.01); A61K 36/74 (2006.01); A61K 9/48 (2006.01); A61K 35/60 (2006.01); A23L 33/10 (2016.01); A23L 33/115 (2016.01); A23L 33/12 (2016.01); A61K 9/00 (2006.01); A61K 36/02 (2006.01); A61K 36/535 (2006.01);
U.S. Cl.
CPC ...
A61K 31/122 (2013.01); A23L 33/10 (2016.08); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A61K 9/0053 (2013.01); A61K 9/48 (2013.01); A61K 9/4858 (2013.01); A61K 31/202 (2013.01); A61K 31/661 (2013.01); A61K 31/6615 (2013.01); A61K 31/685 (2013.01); A61K 31/7028 (2013.01); A61K 31/728 (2013.01); A61K 35/60 (2013.01); A61K 36/02 (2013.01); A61K 36/05 (2013.01); A61K 36/185 (2013.01); A61K 36/324 (2013.01); A61K 36/535 (2013.01); A61K 36/74 (2013.01); A61K 36/9066 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A61K 2236/10 (2013.01); A61K 2236/13 (2013.01); A61K 2236/33 (2013.01); A61K 2236/35 (2013.01); A61K 2236/53 (2013.01);
Abstract

A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.

Find Patent Forward Citations

Loading…